Who owns the TYVASO DPI (TREPROSTINIL) INHALATION POWDER trademark?

The TYVASO DPI (TREPROSTINIL) INHALATION POWDER trademark is owned by United Therapeutics Corporation.

What class is the TYVASO DPI (TREPROSTINIL) INHALATION POWDER trademark registered in?

The TYVASO DPI (TREPROSTINIL) INHALATION POWDER trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for TYVASO DPI (TREPROSTINIL) INHALATION POWDER?

The USPTO serial number for TYVASO DPI (TREPROSTINIL) INHALATION POWDER is 90370409.

What is the registration number for TYVASO DPI (TREPROSTINIL) INHALATION POWDER?

TYVASO DPI (TREPROSTINIL) INHALATION POWDER is registered under USPTO registration number 6756715.

TYV

USPTO Trademark Record

REGISTERED

TYVASO DPI (TREPROSTINIL) INHALATION POWDER

SN 90370409·Reg 6756715·Filed Dec 09, 2020

Owner United Therapeutics Corporation

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

TYVASO DPI (TREPROSTINIL) INHALATION POWDER (Serial No. 90370409), Registration No. 6756715, is a registered US trademark filed on Dec 09, 2020 by United Therapeutics Corporation. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: June 14, 2028

Mark Intelligence

TYVASO DPI (TREPROSTINIL) INHALATION POWDER (Reg. #6756715) is a registered US trademark that has been protecting its owner, United Therapeutics Corporation, since 2020. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 09, 2020

SERIAL

90370409

REG#

6756715

REGISTERED

Jun 14, 2022

Owner

Applicant

United Therapeutics Corporation

Entity

Corporation

State

Address

1040 Spring Street, Silver Spring, MD, 20910

Country

Attorney

NameNorm J. Rich

Law firm

Norm J. Rich FOLEY & LARDNER LLP

Docket

080618-

Address

3000 K STREET, N.W., SIXTH FLOOR, WASHINGTON, DC 20007, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateDec 09, 2020

Serial Number90370409

Registration No.6756715

Registration DateJun 14, 2022

Status DateJun 14, 2022

Published for OppositionMar 29, 2022

Mark TypeDesign with words

Attorney Docket080618-

Status DescriptionLive and registered

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Oct 28, 2020

First use in commerce: Oct 28, 2020

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

26 events

REGISTERED-PRINCIPAL REGISTER

Jun 14, 2022

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jun 14, 2022

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Mar 29, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 29, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 09, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

Feb 18, 2022

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

USE AMENDMENT ACCEPTED

Feb 17, 2022

USE AMENDMENT ACCEPTED

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 17, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO LIE

Feb 16, 2022

ASSIGNED TO LIE

EXAMINER'S AMENDMENT ENTERED

Feb 16, 2022

EXAMINER'S AMENDMENT ENTERED

EXAMINERS AMENDMENT -WRITTEN

Feb 15, 2022

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Feb 15, 2022

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Feb 15, 2022

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

USE AMENDMENT FILED

Nov 30, 2021

USE AMENDMENT FILED

AMENDMENT TO USE PROCESSING COMPLETE

Nov 30, 2021

AMENDMENT TO USE PROCESSING COMPLETE

TEAS AMENDMENT OF USE RECEIVED

Nov 29, 2021

TEAS AMENDMENT OF USE RECEIVED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 18, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 18, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 18, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Jun 10, 2021

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jun 10, 2021

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 10, 2021

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

May 28, 2021

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Feb 17, 2021

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 16, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Dec 12, 2020

NEW APPLICATION ENTERED

TYVASO DPI (TREPROSTINIL) INHALATION POWDER

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by United Therapeutics Corporation

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Norm J. Rich

Resources

Company